These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33426833)

  • 41. Overview of solidification techniques for self-emulsifying drug delivery systems from industrial perspective.
    Mandić J; Zvonar Pobirk A; Vrečer F; Gašperlin M
    Int J Pharm; 2017 Nov; 533(2):335-345. PubMed ID: 28528850
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bioequivalence Comparison of Pediatric Dasatinib Formulations and Elucidation of Absorption Mechanisms Through Integrated PBPK Modeling.
    Vaidhyanathan S; Wang X; Crison J; Varia S; Gao JZH; Saxena A; Good D
    J Pharm Sci; 2019 Jan; 108(1):741-749. PubMed ID: 30439460
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extemporaneous drug formulations.
    Nahata MC; Allen LV
    Clin Ther; 2008 Nov; 30(11):2112-9. PubMed ID: 19108799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Age-Appropriate Formulations Including Pharmaceutical Excipients in Neonatal Medicines.
    Kogermann K; Lass J; Nellis G; Metsvaht T; Lutsar I
    Curr Pharm Des; 2017; 23(38):5779-5789. PubMed ID: 28950820
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Basics of Compounding: Compounding Films.
    Allen LV
    Int J Pharm Compd; 2016; 20(4):298-305. PubMed ID: 28333675
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design and optimization of a child-friendly dispersible tablet containing isoniazid, pyrazinamide, and rifampicin for treating tuberculosis in pediatrics.
    Suárez-González J; Santoveña-Estévez A; Soriano M; Fariña JB
    Drug Dev Ind Pharm; 2020 Feb; 46(2):309-317. PubMed ID: 31944867
    [No Abstract]   [Full Text] [Related]  

  • 47. An integrated approach to individualized optimal dose estimation of medication by means of dosing adjustment measures and Bi-Digital O-Ring Test.
    Lu DP; Omura Y; Lu WI
    Acupunct Electrother Res; 2014; 39(1):1-25. PubMed ID: 24909015
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pediatric Formulations: Knowledge Gaps Limiting the Expedited Preclinical to Clinical Translation in Children.
    Lavan M; Byrn SR; Knipp G
    AAPS PharmSciTech; 2019 Jan; 20(2):73. PubMed ID: 30631973
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pediatric-friendly chocolate-based dosage forms for the oral administration of both hydrophilic and lipophilic drugs fabricated with extrusion-based 3D printing.
    Karavasili C; Gkaragkounis A; Moschakis T; Ritzoulis C; Fatouros DG
    Eur J Pharm Sci; 2020 Apr; 147():105291. PubMed ID: 32135271
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical trials in pediatrics: The drug delivery dimension.
    Osuntokun B
    Adv Drug Deliv Rev; 2006 Apr; 58(1):90-105. PubMed ID: 16529842
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral transmucosal drug delivery for pediatric use.
    Lam JK; Xu Y; Worsley A; Wong IC
    Adv Drug Deliv Rev; 2014 Jun; 73():50-62. PubMed ID: 23999459
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current Status of Pediatric Formulations for Chronic and Acute Children' Diseases: Applications and Future Perspectives.
    Siafaka P; Ipekci E; Caglar EŞ; Ustundag Okur N; Buyukkayhan D
    Medeni Med J; 2021; 36(2):152-162. PubMed ID: 34239768
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Jet injection devices for the needle-free administration of compounds, vaccines, and other agents.
    Logomasini MA; Stout RR; Marcinkoski R
    Int J Pharm Compd; 2013; 17(4):270-80. PubMed ID: 24261141
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Orally disintegrating mini-tablets (ODMTs)--a novel solid oral dosage form for paediatric use.
    Stoltenberg I; Breitkreutz J
    Eur J Pharm Biopharm; 2011 Aug; 78(3):462-9. PubMed ID: 21324357
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MEMS: Enabled Drug Delivery Systems.
    Cobo A; Sheybani R; Meng E
    Adv Healthc Mater; 2015 May; 4(7):969-82. PubMed ID: 25703045
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Factors influencing the acceptability of pediatric galenic formulations].
    Rehn C; Odouard E; Poncet F; Cochat P; Breant V; Dode X
    Ann Pharm Fr; 2018 May; 76(3):163-171. PubMed ID: 29502801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Specific aspects of gastro-intestinal transit in children for drug delivery design.
    Bowles A; Keane J; Ernest T; Clapham D; Tuleu C
    Int J Pharm; 2010 Aug; 395(1-2):37-43. PubMed ID: 20478372
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Performance Comparisons of Jet and Mesh Nebulizers Using Different Interfaces in Simulated Spontaneously Breathing Adults and Children.
    Ari A; de Andrade AD; Sheard M; AlHamad B; Fink JB
    J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):281-9. PubMed ID: 25493535
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Tablet splitting].
    Quinzler R; Haefeli WE
    Ther Umsch; 2006 Jun; 63(6):441-7. PubMed ID: 16841582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.